Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.

Zhang W, Yi Z, Keung KL, Shang H, Wei C, Cravedi P, Sun Z, Xi C, Woytovich C, Farouk S, Huang W, Banu K, Gallon L, Magee CN, Najafian N, Samaniego M, Djamali A, Alexander SI, Rosales IA, Smith RN, Xiang J, Lerut E, Kuypers D, Naesens M, O'Connell PJ, Colvin R, Menon MC, Murphy B.

J Am Soc Nephrol. 2019 Jul 5. pii: ASN.2018111098. doi: 10.1681/ASN.2018111098. [Epub ahead of print]

PMID:
31278196
2.

Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection.

Zhang W, Yi Z, Wei C, Keung KL, Sun Z, Xi C, Woytovich C, Farouk S, Gallon L, Menon MC, Magee C, Najafian N, Samaniego MD, Djamali A, Alexander SI, Rosales IA, Smith RN, O'Connell PJ, Colvin R, Cravedi P, Murphy B.

JCI Insight. 2019 Jun 6;4(11). pii: 127543. doi: 10.1172/jci.insight.127543. eCollection 2019 Jun 6.

3.

Treatment adherence to pegvisomant in patients with acromegaly in Spain: PEGASO study.

Cámara R, Venegas E, García-Arnés JA, Cordido F, Aller J, Samaniego ML, Mir N, Sánchez-Cenizo L.

Pituitary. 2019 Apr;22(2):137-145. doi: 10.1007/s11102-019-00943-1.

PMID:
30756345
4.

Biomarkers of rejection in kidney transplantation.

Singh N, Samant H, Hawxby A, Samaniego MD.

Curr Opin Organ Transplant. 2019 Feb;24(1):103-110. doi: 10.1097/MOT.0000000000000606.

PMID:
30540576
5.

Accelerated podocyte detachment early after kidney transplantation is related to long-term allograft loss of function.

Naik AS, Afshinnia F, Aqeel J, Cibrik DM, Samaniego M, Wickman L, Wang SQ, Chowdhury M, Wiggins RC.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1232-1239. doi: 10.1093/ndt/gfy350.

PMID:
30500951
6.

Increased genetic damage found in waste picker women in a landfill in Paraguay measured by comet assay and the micronucleus test.

Franco de Diana D, Segovia Abreu J, Castiglioni Serafini D, Ortíz JF, Samaniego MJ, Aranda AC, Zamorano-Ponce E.

Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt B):19-23. doi: 10.1016/j.mrgentox.2018.06.011. Epub 2018 Jun 7.

PMID:
30442339
7.

Efficacy of therapeutic plasma exchange on angiotensin II type-1 receptor antibodies on two kidney transplant recipients.

Yamada C, Huang Y, Norman S, Naik A, Moussa O, Samaniego M, Cooling L.

J Clin Apher. 2018 Dec;33(6):673-677. doi: 10.1002/jca.21657. Epub 2018 Oct 15.

PMID:
30321467
8.

Divergent drivers of leaf trait variation within species, among species, and among functional groups.

Osnas JLD, Katabuchi M, Kitajima K, Wright SJ, Reich PB, Van Bael SA, Kraft NJB, Samaniego MJ, Pacala SW, Lichstein JW.

Proc Natl Acad Sci U S A. 2018 May 22;115(21):5480-5485. doi: 10.1073/pnas.1803989115. Epub 2018 May 3.

9.

Temporal trends, center-level variation, and the impact of prevalent state obesity rates on acceptance of obese living kidney donors.

Naik AS, Cibrik DM, Sakhuja A, Samaniego M, Lu Y, Shahinian V, Norman SP, Schnitzler MA, Kasiske BL, Segev DL, Lentine KL.

Am J Transplant. 2018 Mar;18(3):642-649. doi: 10.1111/ajt.14519. Epub 2017 Oct 30.

10.

Defining the phenotype of antibody-mediated rejection in kidney transplantation: Advances in diagnosis of antibody injury.

Garg N, Samaniego MD, Clark D, Djamali A.

Transplant Rev (Orlando). 2017 Oct;31(4):257-267. doi: 10.1016/j.trre.2017.08.005. Epub 2017 Aug 15. Review.

PMID:
28882367
11.

Practices in the evaluation of potential kidney transplant recipients who are elderly: A survey of U.S. transplant centers.

Mandelbrot DA, Fleishman A, Rodrigue JR, Norman SP, Samaniego M.

Clin Transplant. 2017 Oct;31(10). doi: 10.1111/ctr.13088. Epub 2017 Sep 4.

PMID:
28805267
12.

Novel potential predictive markers of sunitinib outcomes in long-term responders versus primary refractory patients with metastatic clear-cell renal cell carcinoma.

Puente J, Laínez N, Dueñas M, Méndez-Vidal MJ, Esteban E, Castellano D, Martinez-Fernández M, Basterretxea L, Juan-Fita MJ, Antón L, León L, Lambea J, Pérez-Valderrama B, Vázquez S, Suarez C, Del Muro XG, Gallardo E, Maroto JP, Samaniego ML, Suárez-Paniagua B, Sanz J, Paramio JM; SOGUG (Spanish Oncology Genitourinary Group).

Oncotarget. 2017 May 2;8(18):30410-30421. doi: 10.18632/oncotarget.16494.

13.

Use of complement binding assays to assess the efficacy of antibody mediated rejection therapy and prediction of graft survival in kidney transplantation.

Ramon DS, Huang Y, Zhao L, Rendulic T, Park JM, Sung RS, Samaniego M.

Hum Immunol. 2017 Feb;78(2):57-63. doi: 10.1016/j.humimm.2016.11.009. Epub 2016 Nov 25.

PMID:
27894836
14.

The Struggle for Optimization of Long-Term Outcomes After Kidney Transplantation.

Patel AK, Samaniego M.

Adv Chronic Kidney Dis. 2016 Sep;23(5):280. doi: 10.1053/j.ackd.2016.09.005. No abstract available.

PMID:
27742380
15.

Coagulation status after therapeutic plasma exchange using citrate in kidney transplant recipients.

Yamada C, Pipe SW, Zhao L, Leichtman AB, Samaniego M, Sung RS, Davenport RD.

Transfusion. 2016 Dec;56(12):3073-3080. doi: 10.1111/trf.13803. Epub 2016 Sep 7.

16.

Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study.

O'Connell PJ, Zhang W, Menon MC, Yi Z, Schröppel B, Gallon L, Luan Y, Rosales IA, Ge Y, Losic B, Xi C, Woytovich C, Keung KL, Wei C, Greene I, Overbey J, Bagiella E, Najafian N, Samaniego M, Djamali A, Alexander SI, Nankivell BJ, Chapman JR, Smith RN, Colvin R, Murphy B.

Lancet. 2016 Sep 3;388(10048):983-93. doi: 10.1016/S0140-6736(16)30826-1. Epub 2016 Jul 22.

17.

Quantitative podocyte parameters predict human native kidney and allograft half-lives.

Naik AS, Afshinnia F, Cibrik D, Hodgin JB, Wu F, Zhang M, Kikuchi M, Wickman L, Samaniego M, Bitzer M, Wiggins JE, Ojo A, Li Y, Wiggins RC.

JCI Insight. 2016;1(7). pii: 86943. doi: 10.1172/jci.insight.86943. Epub 2016 May 19.

18.

Current outcomes of chronic active antibody mediated rejection - A large single center retrospective review using the updated BANFF 2013 criteria.

Redfield RR, Ellis TM, Zhong W, Scalea JR, Zens TJ, Mandelbrot D, Muth BL, Panzer S, Samaniego M, Kaufman DB, Astor BC, Djamali A.

Hum Immunol. 2016 Apr;77(4):346-52. doi: 10.1016/j.humimm.2016.01.018. Epub 2016 Feb 9.

PMID:
26867813
19.

Effect of Treatment With Tabalumab, a B Cell-Activating Factor Inhibitor, on Highly Sensitized Patients With End-Stage Renal Disease Awaiting Transplantation.

Mujtaba MA, Komocsar WJ, Nantz E, Samaniego MD, Henson SL, Hague JA, Lobashevsky AL, Higgins NG, Czader M, Book BK, Anderson MD, Pescovitz MD, Taber TE.

Am J Transplant. 2016 Apr;16(4):1266-75. doi: 10.1111/ajt.13557. Epub 2016 Jan 18.

20.

The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.

OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E.

Transplantation. 2016 Jan;100(1):39-53. doi: 10.1097/TP.0000000000000869. Review.

21.

The two kidney to one kidney transition and transplant glomerulopathy: a podocyte perspective.

Yang Y, Hodgin JB, Afshinnia F, Wang SQ, Wickman L, Chowdhury M, Nishizono R, Kikuchi M, Huang Y, Samaniego M, Wiggins RC.

J Am Soc Nephrol. 2015 Jun;26(6):1450-65. doi: 10.1681/ASN.2014030287. Epub 2014 Nov 11.

22.

Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients.

Yamada C, Ramon DS, Cascalho M, Sung RS, Leichtman AB, Samaniego M, Davenport RD.

Transfusion. 2015 Apr;55(4):727-35; quiz 726. doi: 10.1111/trf.12923. Epub 2014 Nov 11.

23.

Prevalence and clinical features of psoriatic arthritis in psoriasis patients in Spain. Limitations of PASE as a screening tool.

López Estebaránz JL, Zarco-Montejo P, Samaniego ML, García-Calvo C; PREVAL Study Group.

Eur J Dermatol. 2015 Jan-Feb;25(1):57-63. doi: 10.1684/ejd.2014.2449.

PMID:
25333645
24.

Renal failure in a kidney transplant recipient-BK virus nephropathy or rejection?

Singh N, Samaniego M.

Am J Transplant. 2014 Sep;14(9):2189-91. doi: 10.1111/ajt.12790. No abstract available.

25.

Chronic opioid analgesic usage post-kidney transplantation and clinical outcomes.

Kulshrestha S, Barrantes F, Samaniego M, Luan FL.

Clin Transplant. 2014 Sep;28(9):1041-6. doi: 10.1111/ctr.12414.

26.

Living donor transplantation: should we advocate for it?

Samaniego M, Perrone RD.

Nephrol News Issues. 2014 Feb;28(2):22-3. No abstract available.

PMID:
24649751
27.

Early hospital readmissions post-kidney transplantation are associated with inferior clinical outcomes.

Luan FL, Barrantes F, Roth RS, Samaniego M.

Clin Transplant. 2014 Apr;28(4):487-93. doi: 10.1111/ctr.12347.

28.

Diagnosis and management of antibody-mediated rejection: current status and novel approaches.

Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M.

Am J Transplant. 2014 Feb;14(2):255-71. doi: 10.1111/ajt.12589. Epub 2014 Jan 8. Review.

29.

A history of chronic opioid usage prior to kidney transplantation may be associated with increased mortality risk.

Barrantes F, Luan FL, Kommareddi M, Alazem K, Yaqub T, Roth RS, Sung RS, Cibrik DM, Song P, Samaniego M.

Kidney Int. 2013 Aug;84(2):390-6. doi: 10.1038/ki.2013.136. Epub 2013 Apr 24.

30.

Solid-organ transplantation in older adults: current status and future research.

Abecassis M, Bridges ND, Clancy CJ, Dew MA, Eldadah B, Englesbe MJ, Flessner MF, Frank JC, Friedewald J, Gill J, Gries C, Halter JB, Hartmann EL, Hazzard WR, Horne FM, Hosenpud J, Jacobson P, Kasiske BL, Lake J, Loomba R, Malani PN, Moore TM, Murray A, Nguyen MH, Powe NR, Reese PP, Reynolds H, Samaniego MD, Schmader KE, Segev DL, Shah AS, Singer LG, Sosa JA, Stewart ZA, Tan JC, Williams WW, Zaas DW, High KP.

Am J Transplant. 2012 Oct;12(10):2608-22. doi: 10.1111/j.1600-6143.2012.04245.x. Epub 2012 Sep 7.

31.

Preemptive kidney transplantation: has it come of age?

Huang Y, Samaniego M.

Nephrol Ther. 2012 Nov;8(6):428-32. doi: 10.1016/j.nephro.2012.06.004. Epub 2012 Jul 28. Review.

PMID:
22841863
32.

Utilization of evidence-based cardiovascular therapies and achievement of therapeutic goals in patients with peripheral artery disease.

Mostaza JM, Puras E, Blasco M, Lahoz C, Samaniego ML.

Rev Esp Cardiol (Engl Ed). 2012 Aug;65(8):713-8. Epub 2012 May 31. English, Spanish.

PMID:
22658690
34.

Pneumocystis jirovecii pneumonia is rare in renal transplant recipients receiving only one month of prophylaxis.

Anand S, Samaniego M, Kaul DR.

Transpl Infect Dis. 2011 Dec;13(6):570-4. doi: 10.1111/j.1399-3062.2011.00692.x. Epub 2011 Nov 17.

35.

The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantation.

Luan FL, Kommareddi M, Cibrik DM, Samaniego M, Ojo AO.

Clin Transplant. 2012 May-Jun;26(3):403-10. doi: 10.1111/j.1399-0012.2011.01519.x. Epub 2011 Oct 17.

36.

Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema.

Drachenberg CB, Torrealba JR, Nankivell BJ, Rangel EB, Bajema IM, Kim DU, Arend L, Bracamonte ER, Bromberg JS, Bruijn JA, Cantarovich D, Chapman JR, Farris AB, Gaber L, Goldberg JC, Haririan A, Honsová E, Iskandar SS, Klassen DK, Kraus E, Lower F, Odorico J, Olson JL, Mittalhenkle A, Munivenkatappa R, Paraskevas S, Papadimitriou JC, Randhawa P, Reinholt FP, Renaudin K, Revelo P, Ruiz P, Samaniego MD, Shapiro R, Stratta RJ, Sutherland DE, Troxell ML, Voska L, Seshan SV, Racusen LC, Bartlett ST.

Am J Transplant. 2011 Sep;11(9):1792-802. doi: 10.1111/j.1600-6143.2011.03670.x. Epub 2011 Aug 3.

37.

Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes.

Singh N, Djamali A, Lorentzen D, Pirsch JD, Leverson G, Neidlinger N, Voss B, Torrealba JR, Hofmann RM, Odorico J, Fernandez LA, Sollinger HW, Samaniego M.

Transplantation. 2010 Nov 27;90(10):1079-84. doi: 10.1097/TP.0b013e3181f6a07b.

PMID:
21293194
38.

Living donor kidney transplantation at the University of Michigan.

Lee DD, Gooden CW, Nadig SN, Sonnenday CJ, Abbott C, Magee JC, Englesbe MJ, Punch JD, Samaniego M, Merion RM, Sung RS.

Clin Transpl. 2011:77-89.

PMID:
22755404
39.

Influence of recipient race on the outcome of simultaneous pancreas and kidney transplantation.

Luan FL, Kommareddi M, Cibrik DM, Samaniego M, Ojo AO.

Am J Transplant. 2010 Sep;10(9):2074-81. doi: 10.1111/j.1600-6143.2010.03211.x. Epub 2010 Jul 20.

40.

Outcomes of simultaneous liver/kidney transplants are equivalent to kidney transplant alone: a preliminary report.

Hanish SI, Samaniego M, Mezrich JD, Foley DP, Leverson GE, Lorentzen DF, Sollinger HW, Pirsch JD, D'Alessandro AM, Fernandez LA.

Transplantation. 2010 Jul 15;90(1):52-60.

41.

Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipient-negative kidney transplant recipients.

Luan FL, Samaniego M, Kommareddi M, Park JM, Ojo AO.

Transpl Infect Dis. 2010 Dec;12(6):473-9. doi: 10.1111/j.1399-3062.2010.00532.x.

42.

One-year serum albumin is an independent predictor of outcomes in kidney transplant recipients.

Dahlberg R, Muth B, Samaniego M, Hofmann RM, Pirsch J, Djamali A.

J Ren Nutr. 2010 Nov;20(6):392-7. doi: 10.1053/j.jrn.2010.03.008. Epub 2010 May 26.

43.

Renal transplantation in patients with hepatitis C virus antibody. A long national experience.

Morales JM, Marcén R, Andres A, Domínguez-Gil B, Campistol JM, Gallego R, Gutierrez A, Gentil MA, Oppenheimer F, Samaniego ML, Muñoz-Robles J, Serón D.

NDT Plus. 2010 Jun;3(Suppl_2):ii41-ii46.

44.

Nephrology Quiz and Questionnaire: 2009.

Glassock RJ, Bargman JM, Palmer BF, Samaniego M, Fervenza FC.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1141-60. doi: 10.2215/CJN.00540110. Epub 2010 May 24. No abstract available.

45.

Transplantation in diabetic kidney failure patients: modalities, outcomes, and clinical management.

Luan FL, Samaniego M.

Semin Dial. 2010 Mar-Apr;23(2):198-205. doi: 10.1111/j.1525-139X.2010.00708.x. Epub 2010 Mar 30. Review.

46.

Fibrogenesis in kidney transplantation: potential targets for prevention and therapy.

Djamali A, Samaniego M.

Transplantation. 2009 Nov 27;88(10):1149-56. doi: 10.1097/TP.0b013e3181bcccea. Review.

47.

Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival.

Djamali A, Samaniego M, Torrealba J, Pirsch J, Muth BL.

Nephrol Dial Transplant. 2010 Apr;25(4):1300-6. doi: 10.1093/ndt/gfp613. Epub 2009 Nov 23.

PMID:
19934095
48.

BAFF is increased in renal transplant patients following treatment with alemtuzumab.

Bloom D, Chang Z, Pauly K, Kwun J, Fechner J, Hayes C, Samaniego M, Knechtle S.

Am J Transplant. 2009 Aug;9(8):1835-45. doi: 10.1111/j.1600-6143.2009.02710.x. Epub 2009 Jun 12.

49.

Promoting pre-emptive or early kidney transplantation.

Samaniego MD.

Nephrol News Issues. 2009 Mar;23(3):54-5. No abstract available.

PMID:
19353980
50.

Acute rejection in a highly sensitized lung transplant recipient with pre-formed donor-directed anti-HLA class II antibodies: role of bortezomib therapy.

Stuckey LJ, Kamoun M, Wadhwa A, Samaniego M, Bartos C, Berry J, Mahidhara R, Chang AC, Chan KM.

Clin Transpl. 2009:471-4. No abstract available.

PMID:
20524317

Supplemental Content

Loading ...
Support Center